Accendra Health Inc (ACH)vsMeta Platforms Inc. (META)
ACH
Accendra Health Inc
$3.58
-4.28%
HEALTHCARE · Cap: $285.88M
META
Meta Platforms Inc.
$609.63
-1.16%
COMMUNICATION SERVICES · Cap: $1.57T
Smart Verdict
WallStSmart Research — data-driven comparison
Meta Platforms Inc. generates 7683% more annual revenue ($214.96B vs $2.76B). META leads profitability with a 32.8% profit margin vs -39.9%. ACH appears more attractively valued with a PEG of 0.70. META earns a higher WallStSmart Score of 83/100 (A-).
ACH
Hold48
out of 100
Grade: D+
META
Exceptional Buy83
out of 100
Grade: A-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for ACH.
Margin of Safety
+33.9%
Fair Value
$933.07
Current Price
$609.63
$323.44 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Mega-cap, among the largest globally
Every $100 of equity generates 33 in profit
Keeps 33 of every $100 in revenue as profit
Strong operational efficiency at 40.6%
Revenue surging 33.1% year-over-year
Earnings expanding 62.4% YoY
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Operating margin of 2.9%
ROE of -163.8% — below average capital efficiency
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : ACH
The strongest argument for ACH centers on PEG Ratio. PEG of 0.70 suggests the stock is reasonably priced for its growth.
Bull Case : META
The strongest argument for META centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 32.8% and operating margin at 40.6%. Revenue growth of 33.1% demonstrates continued momentum.
Bear Case : ACH
The primary concerns for ACH are EPS Growth, Market Cap, Operating Margin.
Bear Case : META
The primary concerns for META are Piotroski F-Score.
Key Dynamics to Monitor
ACH profiles as a turnaround stock while META is a growth play — different risk/reward profiles.
ACH carries more volatility with a beta of 1.70 — expect wider price swings.
META is growing revenue faster at 33.1% — sustainability is the question.
META generates stronger free cash flow (13.2B), providing more financial flexibility.
Bottom Line
META scores higher overall (83/100 vs 48/100), backed by strong 32.8% margins and 33.1% revenue growth. Both earn "Exceptional Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Accendra Health Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Aluminum Corporation of China Limited, manufactures and sells alumina, primary aluminum and energy products in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.
Meta Platforms Inc.
COMMUNICATION SERVICES · INTERNET CONTENT & INFORMATION · USA
Meta Platforms, Inc. develops products that enable people to connect and share with friends and family through mobile devices, PCs, virtual reality headsets, wearables and home devices around the world. The company is headquartered in Menlo Park, California.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?